BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wreghitt TG, Teare EL, Sule O, Devi R, Rice P. Cytomegalovirus infection in immunocompetent patients. Clin Infect Dis. 2003;37:1603-1606. [PMID: 14689339 DOI: 10.1086/379711] [Cited by in Crossref: 105] [Cited by in F6Publishing: 82] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Ceccarelli M, Venanzi Rullo E, Nunnari G. Risk factors of venous thrombo-embolism during cytomegalovirus infection in immunocompetent individuals. A systematic review. Eur J Clin Microbiol Infect Dis 2018;37:381-90. [PMID: 29344839 DOI: 10.1007/s10096-018-3185-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
2 Zahid M, Ali N, Saad M, Kelly P, Ortiz A. Acute Cytomegalovirus (CMV) Hepatitis in an Immunocompetent Adult. Am J Case Rep 2020;21:e925495. [PMID: 32673293 DOI: 10.12659/AJCR.925495] [Reference Citation Analysis]
3 van der Sande MA, Kaye S, Miles DJ, Waight P, Jeffries DJ, Ojuola OO, Palmero M, Pinder M, Ismaili J, Flanagan KL, Aveika AA, Zaman A, Rowland-Jones S, McConkey SJ, Whittle HC, Marchant A. Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort. PLoS One 2007;2:e492. [PMID: 17551573 DOI: 10.1371/journal.pone.0000492] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 3.8] [Reference Citation Analysis]
4 Morris G, Berk M, Walder K, Maes M. The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability. Mol Neurobiol 2016;53:2550-71. [PMID: 26081141 DOI: 10.1007/s12035-015-9262-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
5 Fulkerson HL, Nogalski MT, Collins-McMillen D, Yurochko AD. Overview of Human Cytomegalovirus Pathogenesis. Methods Mol Biol 2021;2244:1-18. [PMID: 33555579 DOI: 10.1007/978-1-0716-1111-1_1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Alibegovic E, Kurtcehajic A, Ilic B, Hujdurovic A, Smajic E, Habibovic A, Perkunic D. Cytomegalovirus Cholangiopathy in an Immunocompetent Patient: A Case Report and Literature Review. Case Reports Hepatol 2021;2021:2420668. [PMID: 34804619 DOI: 10.1155/2021/2420668] [Reference Citation Analysis]
7 Harms RZ, Lorenzo-Arteaga KM, Ostlund KR, Smith VB, Smith LM, Gottlieb P, Sarvetnick N. Abnormal T Cell Frequencies, Including Cytomegalovirus-Associated Expansions, Distinguish Seroconverted Subjects at Risk for Type 1 Diabetes. Front Immunol 2018;9:2332. [PMID: 30405601 DOI: 10.3389/fimmu.2018.02332] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
8 Yu Z, Wang Y, Liu L, Zhang X, Jiang S, Wang B. Apoptosis Disorder, a Key Pathogenesis of HCMV-Related Diseases. Int J Mol Sci 2021;22:4106. [PMID: 33921122 DOI: 10.3390/ijms22084106] [Reference Citation Analysis]
9 Gonçalves C, Cipriano A, Videira Santos F, Abreu M, Méndez J, Sarmento E Castro R. Cytomegalovirus acute infection with pulmonary involvement in an immunocompetent patient. IDCases 2018;14:e00445. [PMID: 30191130 DOI: 10.1016/j.idcr.2018.e00445] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
10 Vasto S, Colonna-Romano G, Larbi A, Wikby A, Caruso C, Pawelec G. Role of persistent CMV infection in configuring T cell immunity in the elderly. Immun Ageing 2007;4:2. [PMID: 17376222 DOI: 10.1186/1742-4933-4-2] [Cited by in Crossref: 77] [Cited by in F6Publishing: 62] [Article Influence: 5.1] [Reference Citation Analysis]
11 Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J. 2008;5:47. [PMID: 18371229 DOI: 10.1186/1743-422x-5-47] [Cited by in Crossref: 299] [Cited by in F6Publishing: 148] [Article Influence: 21.4] [Reference Citation Analysis]
12 Abgueguen P, Delbos V, Ducancelle A, Jomaa S, Fanello S, Pichard E. Venous thrombosis in immunocompetent patients with acute cytomegalovirus infection: a complication that may be underestimated. Clinical Microbiology and Infection 2010;16:851-4. [DOI: 10.1111/j.1469-0691.2009.03022.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
13 Nolan N, Halai UA, Regunath H, Smith L, Rojas-Moreno C, Salzer W. Primary cytomegalovirus infection in immunocompetent adults in the United States - A case series. IDCases 2017;10:123-6. [PMID: 29159070 DOI: 10.1016/j.idcr.2017.10.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
14 Orasch C, Conen A. Severe primary cytomegalovirus infection in the immunocompetent adult patient: a case series. Scand J Infect Dis 2012;44:987-91. [PMID: 22831702 DOI: 10.3109/00365548.2012.697637] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
15 Scarborough JA, Paul JR, Spencer JV. Evolution of the ability to modulate host chemokine networks via gene duplication in human cytomegalovirus (HCMV). Infect Genet Evol. 2017;51:46-53. [PMID: 28315475 DOI: 10.1016/j.meegid.2017.03.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
16 Etienne S, Leuzinger K, Hirsch HH, Osthoff M. Challenges of Primary Care Medicine in a Tertiary Care Setting—The Case of Primary CMV Infection Compared to Primary EBV Infection: A Retrospective Cohort Study. Front Med 2022;9:880610. [DOI: 10.3389/fmed.2022.880610] [Reference Citation Analysis]
17 De Silva SR, Chohan G, Jones D, Hu M. Cytomegalovirus papillitis in an immunocompetent patient. J Neuroophthalmol 2008;28:126-7. [PMID: 18562845 DOI: 10.1097/WNO.0b013e3181782fed] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
18 Pusztai R, Lukácsi A, Kovács I. Mother-to-fetus transmission of cytomegalovirus. A review. Acta Microbiol Immunol Hung 2004;51:385-401. [PMID: 15704329 DOI: 10.1556/AMicr.51.2004.4.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Miranda RN, Khoury JD, Medeiros LJ. Cytomegalovirus Lymphadenitis. Atlas of Lymph Node Pathology. New York: Springer; 2013. pp. 71-3. [DOI: 10.1007/978-1-4614-7959-8_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Deconinck L, Flateau C, Pichenot M, Morell-dubois S, Maillard H, Hatron P, Guery B, Faure K. Antiviral therapy of primary cytomegalovirus infection with vascular thrombosis in immunocompetent adults. Médecine et Maladies Infectieuses 2016;46:87-92. [DOI: 10.1016/j.medmal.2015.12.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
21 Trukhmanov AS, Makushina AA, Storonova OA, Ivashkina NY. [Evaluation and management of infectious esophagitis in immunocompromised patients and immunocompetent individuals]. Ter Arkh 2020;92:108-17. [PMID: 33346470 DOI: 10.26442/00403660.2020.08.000763] [Reference Citation Analysis]
22 Martin SI, Sepehr A, Fishman JA. Primary infection with cytomegalovirus in ulcerative colitis. Dig Dis Sci. 2006;51:2184-2187. [PMID: 17120145 DOI: 10.1007/s10620-006-9474-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
23 Bertoni M, Squizzato A, Foretic M, Zanieri S, Di Natale ME. Cytomegalovirus-associated splanchnic vein thrombosis in immunocompetent patients: A systematic review. Thrombosis Research 2018;168:104-13. [DOI: 10.1016/j.thromres.2018.06.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
24 Collins-McMillen D, Kim JH, Nogalski MT, Stevenson EV, Chan GC, Caskey JR, Cieply SJ, Yurochko AD. Human Cytomegalovirus Promotes Survival of Infected Monocytes via a Distinct Temporal Regulation of Cellular Bcl-2 Family Proteins. J Virol 2015;90:2356-71. [PMID: 26676786 DOI: 10.1128/JVI.01994-15] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
25 Osawa R, Singh N. Cytomegalovirus infection in critically ill patients: a systematic review. Crit Care 2009;13:R68. [PMID: 19442306 DOI: 10.1186/cc7875] [Cited by in Crossref: 115] [Cited by in F6Publishing: 99] [Article Influence: 8.8] [Reference Citation Analysis]
26 Mao G, Li H, Ding X, Meng X, Wang G, Leng SX. Suppressive effects of sirtinol on human cytomegalovirus (hCMV) infection and hCMV-induced activation of molecular mechanisms of senescence and production of reactive oxygen species. Mech Ageing Dev 2016;158:62-9. [PMID: 26763147 DOI: 10.1016/j.mad.2015.12.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
27 Arend SM, Kroes AC. Look and ye shall find...cytomegalovirus infection in immunocompetent patients. Clin Infect Dis 2003;37:1607-8. [PMID: 14689340 DOI: 10.1086/379720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
28 Khiatah B, Nasrollah L, Covington S, Carlson D. Nonalcoholic fatty liver disease as a risk factor for cytomegalovirus hepatitis in an immunocompetent patient: A case report. World J Clin Cases 2021; 9(6): 1455-1460 [PMID: 33644215 DOI: 10.12998/wjcc.v9.i6.1455] [Reference Citation Analysis]
29 Aiello A, Accardi G, Candore G, Caruso C, Colomba C, Di Bona D, Duro G, Gambino CM, Ligotti ME, Pandey JP. Role of Immunogenetics in the Outcome of HCMV Infection: Implications for Ageing. Int J Mol Sci 2019;20:E685. [PMID: 30764515 DOI: 10.3390/ijms20030685] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
30 Batalla AS, Benito D, Baumard S, Brodard V, Servettaz A, Jaussaud R, Strady C. [Epstein-Barr virus and cytomegalovirus primary infections: a comparative study in 52 immunocompetent adults]. Med Mal Infect 2011;41:14-9. [PMID: 20832213 DOI: 10.1016/j.medmal.2010.07.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
31 Zheng L, Li H, Fu L, Liu S, Yan Q, Leng SX. Blocking cellular N-glycosylation suppresses human cytomegalovirus entry in human fibroblasts. Microb Pathog 2020;138:103776. [PMID: 31600539 DOI: 10.1016/j.micpath.2019.103776] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
32 Bosch JA, Rector JL, Turner JE, Riddell NE, o‘Hartaigh B, Burns VE. Psychoneuromicrobiology: Cytomegalovirus Infection as a Putative Link Between Stress, Aging, and Immunity. In: Bosch JA, Phillips AC, Lord JM, editors. Immunosenescence. New York: Springer; 2013. pp. 81-100. [DOI: 10.1007/978-1-4614-4776-4_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Boeck JM, Stowell GA, O'Connor CM, Spencer JV. The Human Cytomegalovirus US27 Gene Product Constitutively Activates Antioxidant Response Element-Mediated Transcription through Gβγ, Phosphoinositide 3-Kinase, and Nuclear Respiratory Factor 1. J Virol 2018;92:e00644-18. [PMID: 30209167 DOI: 10.1128/JVI.00644-18] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
34 Vandamme YM, Ducancelle A, Biere L, Viot N, Rouleau F, Delbos V, Abgueguen P. Myopericarditis complicated by pulmonary embolism in an immunocompetent patient with acute cytomegalovirus infection: a case report. BMC Res Notes 2014;7:193. [PMID: 24678987 DOI: 10.1186/1756-0500-7-193] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
35 Šimeková K, Nováková E, Rosoľanka R, Masná J, Antolová D. Clinical Course of Opportunistic Infections-Toxoplasmosis and Cytomegalovirus Infection in HIV-Infected Patients in Slovakia. Pathogens 2019;8:E219. [PMID: 31690039 DOI: 10.3390/pathogens8040219] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Nangle S, Mitra S, Roskos S, Havlichek D. Cytomegalovirus infection in immunocompetent adults: Is observation still the best strategy? IDCases 2018;14:e00442. [PMID: 30202727 DOI: 10.1016/j.idcr.2018.e00442] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
37 Thackeray R, Magnusson BM, Bennion E, Nielsen NN, Bailey RJ. Attitudes of U.S. Hispanic and non-Hispanic women toward congenital CMV prevention behaviors: a cross sectional study. BMC Pregnancy Childbirth 2018;18:181. [PMID: 29793438 DOI: 10.1186/s12884-018-1807-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
38 Revello MG, Gerna G. Maternal, fetal and neonatal diagnosis of congenital human cytomegalovirus infection. Expert Opinion on Medical Diagnostics 2008;2:547-63. [DOI: 10.1517/17530059.2.5.547] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
39 Chakrabarty A, Pang KR, Wu JJ, Narvaez J, Rauser M, Huang DB, Beutner KR, Tyring SK. Emerging therapies for herpes viral infections (types 1 – 8). Expert Opinion on Emerging Drugs 2005;9:237-56. [DOI: 10.1517/14728214.9.2.237] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
40 Yee-guardino S, Gowans K, Yen-lieberman B, Berk P, Kohn D, Wang F, Danziger-isakov L, Sabella C, Worley S, Pellett PE, Goldfarb J. β-Herpesviruses in Febrile Children with Cancer. Emerg Infect Dis 2008;14:579-85. [DOI: 10.3201/eid1404.070651] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
41 Crumpacker Ii CS, Zhang JL. Cytomegalovirus. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Elsevier; 2010. pp. 1971-87. [DOI: 10.1016/b978-0-443-06839-3.00138-7] [Cited by in Crossref: 8] [Article Influence: 0.7] [Reference Citation Analysis]
42 Koch S, Solana R, Dela Rosa O, Pawelec G. Human cytomegalovirus infection and T cell immunosenescence: a mini review. Mech Ageing Dev 2006;127:538-43. [PMID: 16513159 DOI: 10.1016/j.mad.2006.01.011] [Cited by in Crossref: 100] [Cited by in F6Publishing: 91] [Article Influence: 6.3] [Reference Citation Analysis]
43 Pawelec G. Human Immunosenescence: Does It Have an Infectious Component? Annals of the New York Academy of Sciences 2006;1067:56-65. [DOI: 10.1196/annals.1354.009] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 3.9] [Reference Citation Analysis]
44 Cinti S. Ocular Cytomegalovirus Infection: A Challenging Diagnosis. Journal of Neuro-Ophthalmology 2008;28:91-2. [DOI: 10.1097/wno.0b013e31817728da] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Pusztai R. Cytomegalovirus infection in pregnancy. Clinical and Experimental Medical Journal 2009;3:227-35. [DOI: 10.1556/cemed.3.2009.28617] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
46 Bernstein S, Meskey T, Helm K, Miller J, Foulke G, Chung C. Localized cutaneous sclerodermoid changes secondary to human cytomegalovirus infection: An uncommon presentation in an immunocompetent host. JAAD Case Rep 2016;2:119-21. [PMID: 27051849 DOI: 10.1016/j.jdcr.2016.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
47 Bunchorntavakul C, Reddy KR. Epstein-Barr Virus and Cytomegalovirus Infections of the Liver. Gastroenterol Clin North Am 2020;49:331-46. [PMID: 32389366 DOI: 10.1016/j.gtc.2020.01.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Cunha BA, Chawla K. Fever of unknown origin (FUO): CMV infectious mononucleosis or lymphoma? Eur J Clin Microbiol Infect Dis 2018;37:1373-6. [PMID: 29679253 DOI: 10.1007/s10096-018-3262-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
49 Pawelec G, McElhaney JE, Aiello AE, Derhovanessian E. The impact of CMV infection on survival in older humans. Curr Opin Immunol 2012;24:507-11. [PMID: 22541724 DOI: 10.1016/j.coi.2012.04.002] [Cited by in Crossref: 89] [Cited by in F6Publishing: 74] [Article Influence: 8.9] [Reference Citation Analysis]
50 Freeman AJ, Bishop PR, Subramony C, Nowicki MJ. Life-Threatening Cytomegalovirus Enteritis and Pneumonia in an Immunocompetent Adolescent: A Case Report and Brief Literature Review. Clin Pediatr (Phila) 2012;51:507-11. [DOI: 10.1177/0009922811398962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
51 Grosjean J, Trapes L, Hantz S, Mengelle C, Virey B, Undreiner F, Messager V, Denis F, Marin B, Alain S. Human cytomegalovirus quantification in toddlers saliva from day care centers and emergency unit: a feasibility study. J Clin Virol 2014;61:371-7. [PMID: 25183358 DOI: 10.1016/j.jcv.2014.07.020] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
52 Koch S, Larbi A, Ozcelik D, Solana R, Gouttefangeas C, Attig S, Wikby A, Strindhall J, Franceschi C, Pawelec G. Cytomegalovirus infection: a driving force in human T cell immunosenescence. Ann N Y Acad Sci 2007;1114:23-35. [PMID: 17986574 DOI: 10.1196/annals.1396.043] [Cited by in Crossref: 166] [Cited by in F6Publishing: 152] [Article Influence: 11.9] [Reference Citation Analysis]
53 Faycal A, Ndoadoumgue AL, Sellem B, Blanc C, Dudoit Y, Schneider L, Tubiana R, Valantin MA, Seang S, Palich R, Bleibtreu A, Monsel G, Godefroy N, Itani O, Paccoud O, Pourcher V, Caumes E, Ktorza N, Chermak A, Abdi B, Assoumou L, Katlama C; COVIDOM-19 PSL research group. Prevalence and factors associated with symptom persistence: A prospective study of 429 mild COVID-19 outpatients. Infect Dis Now 2021:S2666-9919(21)00540-6. [PMID: 34800742 DOI: 10.1016/j.idnow.2021.11.003] [Reference Citation Analysis]
54 Nogalski MT, Collins-McMillen D, Yurochko AD. Overview of human cytomegalovirus pathogenesis. Methods Mol Biol 2014;1119:15-28. [PMID: 24639215 DOI: 10.1007/978-1-62703-788-4_2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
55 Leng SX, Kamil J, Purdy JG, Lemmermann NA, Reddehase MJ, Goodrum FD. Recent advances in CMV tropism, latency, and diagnosis during aging. Geroscience 2017;39:251-9. [PMID: 28681110 DOI: 10.1007/s11357-017-9985-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
56 Subramanian V, Finlayson C, Harrison T, Rice P, Pollok R. Primary cytomegalovirus infectious colitis complicating Crohn’s disease successfully treated with oral valganciclovir. J Crohns Colitis. 2010;4:199-202. [PMID: 21122506 DOI: 10.1016/j.crohns.2009.11.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
57 Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, Flament T, Ferreira-Maldent N, Bruyère F, Stefic K, Gaudy-Graffin C, Grammatico-Guillon L, Bernard L. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect 2021;27:258-63. [PMID: 33031948 DOI: 10.1016/j.cmi.2020.09.052] [Cited by in Crossref: 97] [Cited by in F6Publishing: 85] [Article Influence: 48.5] [Reference Citation Analysis]
58 McCoy MH, Post K, Sen JD, Chang HY, Zhao Z, Fan R, Chen S, Leland D, Cheng L, Lin J. qPCR increases sensitivity to detect cytomegalovirus in formalin-fixed, paraffin-embedded tissue of gastrointestinal biopsies. Hum Pathol. 2014;45:48-53. [PMID: 24139212 DOI: 10.1016/j.humpath.2013.07.040] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
59 Leng SX, Li H, Xue QL, Tian J, Yang X, Ferrucci L, Fedarko N, Fried LP, Semba RD. Association of detectable cytomegalovirus (CMV) DNA in monocytes rather than positive CMV IgG serology with elevated neopterin levels in community-dwelling older adults. Exp Gerontol 2011;46:679-84. [PMID: 21513787 DOI: 10.1016/j.exger.2011.04.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 16] [Article Influence: 0.3] [Reference Citation Analysis]
60 Frascaroli G, Varani S, Mastroianni A, Britton S, Gibellini D, Rossini G, Landini MP, Söderberg-nauclér C. Dendritic cell function in cytomegalovirus-infected patients with mononucleosis. Journal of Leukocyte Biology 2006;79:932-40. [DOI: 10.1189/jlb.0905499] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
61 Orlikowski D, Quijano-roy S, Sivadon-tardy V, Raphael J, Gaillard J. Infections à Campylobacter jejuni et à cytomégalovirus (CMV) associées au syndrome de Guillain-Barré (SGB). Archives de Pédiatrie 2006;13:1561-5. [DOI: 10.1016/j.arcped.2006.09.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
62 Orlikowski D, Porcher R, Sivadon-tardy V, Quincampoix J, Raphael J, Durand M, Sharshar T, Roussi J, Caudie C, Annane D, Rozenberg F, Leruez-ville M, Gaillard J, Gault E. Guillain-Barre Syndrome following Primary Cytomegalovirus Infection: A Prospective Cohort Study. Clinical Infectious Diseases 2011;52:837-44. [DOI: 10.1093/cid/cir074] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 6.4] [Reference Citation Analysis]
63 Wang GC, Chiu Y, Walston JD. CMV Infection and Frailty: Immunologic Consequences and Disease Pathogenesis. In: Fulop T, Franceschi C, Hirokawa K, Pawelec G, editors. Handbook of Immunosenescence. Cham: Springer International Publishing; 2019. pp. 2391-416. [DOI: 10.1007/978-3-319-99375-1_63] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
64 Pass RF. Human Herpesviruses: Cytomegalovirus. In: Kaslow RA, Stanberry LR, Le Duc JW, editors. Viral Infections of Humans. Boston: Springer US; 2014. pp. 805-28. [DOI: 10.1007/978-1-4899-7448-8_35] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
65 Leonardsson H, Hreinsson JP, Löve A, Björnsson ES. Hepatitis due to Epstein-Barr virus and cytomegalovirus: clinical features and outcomes. Scand J Gastroenterol 2017;52:893-7. [PMID: 28446048 DOI: 10.1080/00365521.2017.1319972] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
66 Bottieau E, Clerinx J, Van den Enden E, Van Esbroeck M, Colebunders R, Van Gompel A, Van den Ende J. Infectious Mononucleosis–Like Syndromes in Febrile Travelers Returning From the Tropics. J Travel Med 2006;13:191-7. [DOI: 10.1111/j.1708-8305.2006.00049.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
67 Bae SH, Kim TW, Chung H, Heo JW. Cytomegalovirus retinitis after intravitreal bevacizumab injection in an immunocompetent patient. Korean J Ophthalmol 2013;27:61-3. [PMID: 23372384 DOI: 10.3341/kjo.2013.27.1.61] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
68 Kuo C, Wu C, Ho H, Chen C, Liu S, Lu Y. Detection of cytomegalovirus reactivation in cancer patients receiving chemotherapy. Clinical Microbiology and Infection 2008;14:221-7. [DOI: 10.1111/j.1469-0691.2007.01895.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
69 Périllaud-Dubois C, Bouthry E, Jadoui A, Leng AL, Roque-Afonso AM, Vauloup-Fellous C. Positive predictive values of CMV-IgM and importance of CMV-IgG avidity testing in detecting primary infection in three different clinical settings. A French retrospective cohort study. J Clin Virol 2020;132:104641. [PMID: 32947202 DOI: 10.1016/j.jcv.2020.104641] [Reference Citation Analysis]
70 Pawelec G, Derhovanessian E, Larbi A, Strindhall J, Wikby A. Cytomegalovirus and human immunosenescence: Immunosenescence & CMV. Rev Med Virol 2009;19:47-56. [DOI: 10.1002/rmv.598] [Cited by in Crossref: 242] [Cited by in F6Publishing: 213] [Article Influence: 17.3] [Reference Citation Analysis]
71 Ross SA, Shimamura M, Boppana SB. CMV Infections. In: Elzouki AY, Harfi HA, Nazer HM, Stapleton FB, Oh W, Whitley RJ, editors. Textbook of Clinical Pediatrics. Berlin: Springer Berlin Heidelberg; 2012. pp. 1145-61. [DOI: 10.1007/978-3-642-02202-9_106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
72 Vetter M, Battegay M, Trendelenburg M. Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis. Infection 2010;38:331-4. [DOI: 10.1007/s15010-010-0024-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
73 Trzonkowski P, Myśliwska J, Pawelec G, Myśliwski A. From bench to bedside and back: the SENIEUR Protocol and the efficacy of influenza vaccination in the elderly. Biogerontology 2009;10:83-94. [DOI: 10.1007/s10522-008-9155-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
74 Wang C, Dollard SC, Amin MM, Bialek SR. Cytomegalovirus IgM Seroprevalence among Women of Reproductive Age in the United States. PLoS One 2016;11:e0151996. [PMID: 26990759 DOI: 10.1371/journal.pone.0151996] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
75 Luís H, Barros C, Gomes M, Andrade JL, Faria N. Cytomegalovirus Pulmonary Involvement in an Immunocompetent Adult. Case Rep Infect Dis 2021;2021:4226386. [PMID: 34422419 DOI: 10.1155/2021/4226386] [Reference Citation Analysis]
76 Li H, Mao G, Carlson J, Leng SX. A novel flow cytometry-based tool for determining the efficiency of human cytomegalovirus infection in THP-1 derived macrophages. J Virol Methods 2015;221:127-30. [PMID: 25958130 DOI: 10.1016/j.jviromet.2015.04.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
77 Pawelec G, Akbar A, Caruso C, Solana R, Grubeck-Loebenstein B, Wikby A. Human immunosenescence: is it infectious? Immunol Rev 2005;205:257-68. [PMID: 15882359 DOI: 10.1111/j.0105-2896.2005.00271.x] [Cited by in Crossref: 285] [Cited by in F6Publishing: 242] [Article Influence: 16.8] [Reference Citation Analysis]
78 Kim JY, Singer EJ, Bonelli L, Klausner JD. A case of primary HIV type 1 and cytomegalovirus coinfection presenting with widespread clinical disease. J Int Assoc Provid AIDS Care 2014;13:196-9. [PMID: 24476962 DOI: 10.1177/2325957413519289] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
79 Maple PA, Tanasescu R, Gran B, Constantinescu CS. A different response to cytomegalovirus (CMV) and Epstein–Barr virus (EBV) infection in UK people with multiple sclerosis (PwMS) compared to controls. Journal of Infection 2020;80:320-5. [DOI: 10.1016/j.jinf.2019.10.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
80 Yang Z, Tang X, Hasing ME, Pang X, Ghosh S, McMullen TPW, Brindley DN, Hemmings DG. Human Cytomegalovirus Seropositivity and Viral DNA in Breast Tumors Are Associated with Poor Patient Prognosis. Cancers (Basel) 2022;14:1148. [PMID: 35267456 DOI: 10.3390/cancers14051148] [Reference Citation Analysis]
81 Pichenot M, Morell-dubois S, Flateau C, Deconinck L, Hatron P, Lambert M. Acute cytomegalovirus infection as a transient risk factor for thrombosis: Report of three cases and focus on specific coagulation pathways. Thrombosis Research 2013;132:145-7. [DOI: 10.1016/j.thromres.2013.04.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
82 Yu SC, Ko KY, Teng SC, Huang TC, Lo HT, Cheng CL, Yao M, Hong RL, Chen CN, Chen TC, Yang TL. A Clinicopathological Study of Cytomegalovirus Lymphadenitis and Tonsillitis and Their Association with Epstein-Barr Virus. Infect Dis Ther 2021;10:2661-75. [PMID: 34623624 DOI: 10.1007/s40121-021-00528-1] [Reference Citation Analysis]
83 Studemeister A. Cytomegalovirus proctitis: a rare and disregarded sexually transmitted disease. Sex Transm Dis 2011;38:876-8. [PMID: 21844745 DOI: 10.1097/OLQ.0b013e31821a5a90] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
84 Godsell J, Chan S, Slade C, Bryant V, Douglass JA, Sasadeusz J, Yong MK. Cytomegalovirus in primary immunodeficiency. Curr Opin Infect Dis 2021;34:663-71. [PMID: 34608876 DOI: 10.1097/QCO.0000000000000797] [Reference Citation Analysis]
85 Farooq PD, Urrunaga NH, Tang DM, von Rosenvinge EC. Pseudomembranous colitis. Dis Mon. 2015;61:181-206. [PMID: 25769243 DOI: 10.1016/j.disamonth.2015.01.006] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 5.9] [Reference Citation Analysis]
86 Hornig J, Choi KY, McGregor A. The essential role of guinea pig cytomegalovirus (GPCMV) IE1 and IE2 homologs in viral replication and IE1-mediated ND10 targeting. Virology 2017;504:122-40. [PMID: 28189970 DOI: 10.1016/j.virol.2017.01.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
87 Hutchison RE, Schexneider KI. Leukocytic Disorders. Henry's Clinical Diagnosis and Management by Laboratory Methods. Elsevier; 2011. pp. 601-55. [DOI: 10.1016/b978-1-4377-0974-2.00033-6] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
88 Maple PAC. Cytomegalovirus and Epstein-Barr Virus Associations with Neurological Diseases and the Need for Vaccine Development. Vaccines (Basel) 2020;8:E35. [PMID: 31968673 DOI: 10.3390/vaccines8010035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]